Nordic Capital Fund V sells Atos Medical to EQT VI | Nordic Capital

Nordic Capital Fund V sells Atos Medical to EQT VI

JULY 20 2011

Nordic Capital Fund V ("Nordic Capital") today announced the divestment of the medical devices company Atos Medical to EQT VI. The parties have agreed not to disclose the terms of the transaction. Atos Medical, headquartered in Hörby in southern Sweden, was acquired by Nordic Capital in 2005 from Fisher Scientific International.

Atos Medical is the undisputed global market leader and provider of proprietary medical devices focused on laryngology, including heat and moisture exchangers and voice prosthesis. It leads in all aspects of the value chain, including R&D, design, manufacturing, marketing and distribution. In 2010, the annual revenues increased to €64m, and since Nordic Capital's acquisition, the company has had a continuous track record of double digit growth.

"During Nordic Capital's ownership of Atos Medical, the company has continued its positive development and strong international growth, organically as well as through acquisitions. I am certain it will remain the brand of choice among surgeons and speech pathologists, and continue to improve the quality of patients' lives", said Christian Frick at NC Advisory AB, advisor to the Nordic Capital Funds.

"During these years, we have received unprecedented commitment from Nordic Capital, and their active ownership has been instrumental in supporting Atos Medical's strengthening of its global market leading position in its field. Our passion has always been to improve quality of life for patients and yet so many more have to benefit. Our journey that has almost just begun will now continue to next levels with EQT VI as an effective and supportive owner", said Tommy Hedberg, CEO of Atos Medical. 

For more information, please contact:
Mikael Widell, Communications Manager, NC
Advisory AB Tel: +46 703 11 99 60

About Atos Medical

Atos Medical is a global medical technology company that develops, manufactures and markets products within the ear, nose and throat areas. It was founded in Sweden in 1986 by the two brothers Gert and Jan Ove Persson. It sells its products via nine sales companies in the US and Europe, and a network of distributors in about 50 countries. It is owned by Nordic Capital Fund V since 2005, with the board directors and employees of the company holding a minority stake (5.4%). It is headquartered in Hörby, Sweden, and has close to 300 employees.